Grant approvals committee
Ambitious national targets for getting people on treatment often not reflected in grant performance frameworks, GAC says
In its report to the Board on the third batch of grants it recommended for approval, the Grant Approvals Committee (GAC) said that it was very concerned that national programs have ambitious goals to continue scaling up antiretroviral therapy (ART), with the aim of achieving the 90-90-90 targets or even treating all patients diagnosed with HIV – but that these goals are not necessarily reflected in performance frameworks because of “limitation
On 1 December 2017, the Global Fund Board approved grants worth $2.83 billion from the 2017-2019 allocations. This is the largest amount approved in a single batch since the start of the new funding model.
The Global Fund has become more prescriptive about what should be included in submissions for funding for the next phase of a grant. While this trend began under the Grant Renewals Panel, the formation of the Grant Approvals Committee (GAC) in the second quarter of 2013 brought with it a noticeable upswing.
A regional HIV grant with a checkered history and serial problems in its aim to respond to stigma and human rights challenges across Latin America and the Caribbean has been discontinued for its failure “to deliver on the original goal of reducing stigma and discrimination and promoting understanding of human rights and gender equity among military and the police,” according to a recommendation by
When the Global Fund Board approved early applicant funding for Myanmar for all three diseases (see first article in this newsletter), it also approved funding for the renewal of existing grants for these diseases. The total funding approved for Myanmar is shown in the following table:
When the Global Fund Board approved early applicant funding for El Salvador for HIV under the new funding model (NFM), it also approved funding for the renewal of two existing HIV grants. The amount of renewal funding approved was $3.9 million. When combined with the $20.2 million in NFM indicative funding and the $2.9 million in NFM incentive funding, total funding awarded to El Salvador was $27.0 million.
The Global Fund Board will not approve funding for Phase 2 of a Round 8 health systems strengthening (HSS) grant in Guinea-Bissau. The Board’s No-Go decision follows notice of an intent to recommend a No-Go for this grant provided by the Global Fund Secretariat in October 2012 (see GFO article).
Five Concept Notes from Early Applicants Have Been Endorsed, and Have Moved to the Grant-Making Stage
Five concept notes submitted by early applicants have been endorsed by the Grant Approvals Committee (GAC). Three of the concept notes are from the country coordinating mechanism (CCM) in Myanmar (one for each disease). The others are from CCMs in El Salvador (HIV) and Zimbabwe (HIV). This information was contained in the 15 May issue of the Global Fund’s News Flash.
Twenty global health leaders, implementers and advocates met in mid-January in England for a two-day "Round Table" of informal discussion on two closely related topics: first, how to ensure that implementers of Global Fund grants can have access to adequate and appropriate technical support; and second, what changes this might require in inter-agency collaboration between the Global Fund, UNAIDS, WHO, World Bank, DFID, PEPFAR, the Ga